Unknown

Dataset Information

0

Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests.


ABSTRACT: We examined the usefulness of five COVID-19 antibody detection tests using 114 serum samples at various time points from 34 Japanese COVID-19 patients. We examined Elecsys Anti-SARS-CoV-2 from Roche, and four immunochromatography tests from Hangzhou Laihe Biotech, Artron Laboratories, Chil, and Nadal. In the first week after onset, Elecsys had 40% positivity in Group S (severe cases) but was negative in Group M (mild-moderate cases). The immunochromatography kits showed 40-60% and 0-8% positivity in Groups S and M, respectively. In the second week, Elecsys showed 75% and 50% positivity, and the immunochromatography tests showed 5-80% and 50-75% positivity in Groups S and M, respectively. After the third week, Elecsys showed 100% positivity in both groups. The immunochromatography kits showed 100% positivity in Group S. In Group M, positivity decreased to 50% for Chil and 75-89% for Artron and Lyher. Elecsys and immunochromatography kits had 91-100% specificity. Elecsys had comparable chronological change of cut-off index values in the two groups from the second week to the sixth week. The current SARS-CoV-2 antibody detection tests do not provide meaningful interpretation of severity and infection status. Its use might be limited to short-term epidemiological studies.

SUBMITTER: Wakita M 

PROVIDER: S-EPMC7870088 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications


We examined the usefulness of five COVID-19 antibody detection tests using 114 serum samples at various time points from 34 Japanese COVID-19 patients. We examined Elecsys Anti-SARS-CoV-2 from Roche, and four immunochromatography tests from Hangzhou Laihe Biotech, Artron Laboratories, Chil, and Nadal. In the first week after onset, Elecsys had 40% positivity in Group S (severe cases) but was negative in Group M (mild-moderate cases). The immunochromatography kits showed 40-60% and 0-8% positivit  ...[more]

Similar Datasets

| S-EPMC7300776 | biostudies-literature
| S-EPMC8368235 | biostudies-literature
| S-EPMC7383556 | biostudies-literature
| S-EPMC7508500 | biostudies-literature
| S-EPMC7836838 | biostudies-literature
| S-EPMC8557912 | biostudies-literature
| S-EPMC8071529 | biostudies-literature
| S-EPMC8646979 | biostudies-literature
| S-EPMC7591045 | biostudies-literature
| S-EPMC8045661 | biostudies-literature